Synapse Medicine Initiates Multi-Site Implementation Study with Leading U.S Hospitals
PR98160
NEW YORK, Oct. 6, 2022, /PRNewswire=KYODO JBN/ --
• Synapse Medicine clinical decision support technology analyzes drug-related
risks based on each patient's clinical characteristics and will be studied for
its impact on inpatient pharmacist efficacy and efficiency.
• The Synapse Medicine medication reconciliation tool will be deployed through
an integration with the hospitals' current EPIC EHR workflow.
• The study also has potential to provide improvements to medication regimen
appropriateness which helps reduce risk of ADEs in hospital and after discharge.
Synapse Medicine, a leader in intelligent medication decision technology,
announced today it has initiated a clinical study with Brigham and Women's
Hospital, Boston, MA and the Vanderbilt University Medical Center, Nashville,
TN to measure the benefits and efficacy of its clinical decision support
solution and its medication reconciliation software in a hospital setting. The
principal investigator is Dr. Jeffrey L. Schnipper, MD, MPH, MHM, of the
Brigham's Division of General Internal Medicine and Primary Care and the
Hospital Medicine Unit, and Professor of Medicine at Harvard Medical School.
The study, "Effect of Synapse Medicine Decision Support on Inpatient Pharmacist
Efficacy and Efficiency: A Hybrid Type 2 Implementation Study," engages
hospital pharmacists at two study sites who round with general medicine service
teams and approve inpatient medications. Participants will use Synapse Medicine
point-of-care tools to analyze drug-related risks and optimize medication
appropriateness. They will also perform medication reconciliation for newly
admitted patients. The study will measure the usability of Synapse Medicine
AI-driven clinical decision support and medication reconciliation tools
quantitatively and qualitatively to determine their impact.
Leveraging real-time data for medication regimen appropriateness
Healthcare systems have long been challenged by the task of drug regimen
optimization, a critical aspect in a patient's continuity of care. An
inaccurate medication history or inappropriate drug therapy can burden
care-providers' efficiency, delay treatment, put patients at risk for
preventable adverse drug events (ADEs), and contribute to higher readmission
rates. Hospital-related ADEs are frequent and dangerous, and their management
has been estimated to cost US$28 billion annually.1
"Hospitalized patients often come to us on suboptimal medication regimens,
especially too many medications. But we also encounter medications that react
with each other, incorrect doses based on their kidney function, or medications
that are inappropriate based on their many medical conditions," said Schnipper.
"At the same time that we are treating patients' acute medical conditions, we
also owe it to them to address these longer-standing medication issues and make
sure we don't introduce any new medication-related problems before they return
home."
Technology-based clinical decision support creates efficiencies and improves
patient outcomes
"Optimizing a patient's medication regimen can be a time-consuming and
complicated process, but it is fundamental to ensuring patient safety and
therapeutic success," shared Dr. Clement Goehrs, Synapse Medicine CEO and
Co-Founder. "Collaborating with Brigham and Women's Hospital and Vanderbilt
University Medical Center allows us to demonstrate how our medication decision
support technology improves accuracy and streamlines processes creating more
time for actual patient care and bringing value to all stakeholders."
Synapse Medicine solutions are built on a technology platform that uses machine
learning and natural language processing. It combines real-time drug knowledge
with clinical data to detect potential medication risks and discrepancies that
can lead to ADEs. The suite of clinical decision support tools enables
healthcare professionals to provide enhanced personalized care for patients.
The study will evaluate the prescription analysis, drug monograph and
medication reconciliation solutions for efficiency and accuracy.
About Synapse Medicine
At Synapse Medicine, we believe in medication success, and are dedicated to
making it possible for everyone.
To achieve this goal, we have built an extensive, global medication knowledge
base using algorithms to ensure the most reliable, up-to-date data. On the
front-end, Synapse Medicine provides a SaaS platform and UI components that are
used to prescribe, dispense, and manage medications across the entire patient
journey.
At Synapse Medicine, we are working with world-leading hospitals and digital
health companies in the United States, Europe and Japan to transform today's
medication regimens into tomorrow's medication success.
1. Weiss, A.J., Freeman, W.J., Heslin, K.C. and Barrett, M.L., 2018. Adverse
drug events in US hospitals, 2010 versus 2014. HCUP Statistical Brief, 234.
press@synapse-medicine.com, +33 (0)5 56 35 50 87
Logo - https://mma.prnewswire.com/media/1914883/Synapse_Medicine_Logo.jpg
SOURCE: Synapse Medicine
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。